Home - Clinical Trials Arena
MSD and Eisai’s LEAP gastroesophageal cancer trial sees mixed success. MSD and Eisai’s trial saw mixed success with its two primary endpoints, seeing success in progression-free …
Most significant clinical trials of 2024
Dec 23, 2024 · Most significant clinical trials of 2024. From GLP-1RA and HIV PrEP successes, to flops in DMD and Alzheimer’s, Clinical Trials Arena rounds up the biggest trial read outs of 2024.
Clinical Trials - Clinical Trials Arena
Traws Pharma completes Phase I trials of H5N1 bird flu treatment drug. The four dose levels of the therapy assessed in the trial were well-tolerated by the subjects.
Market Data - Clinical Trials Arena
Japan accounts for 4.7% share of global clinical trial activity in 2022. Japan has accounted for a 4.7% share of the global clinical trials activity in 2022, registering a decrease when compared…
Latest News - Clinical Trials Arena
Hard data and deep insights on clinical trials strategy & operations. About us; Advertise with us; License our content; Contact us; Editorial approach
About Us Online - Clinical Trials Arena
Clinicaltrialsarena.com covers every aspect of the drug development and research process, from conception to pre-FDA approval.. Our global network of journalists updates the site with the …
News - Clinical Trials Arena
First patient dosed in Phase Ib Pompe disease trial. Aro Biotherapeutics has dosed the first patient in a Phase Ib trial of ABX1100, a novel treatment for late-onset Pompe…
About Us - Clinical Trials Arena
About Us. Clinicaltrialsarena.com is one of a network of 40+ proprietary B2B websites, with an unrivalled global audience of active decision makers, influencers, and opinion leaders across …
Reports - Clinical Trials Arena
GlobalData’s reports offer expert analysis, insights and opinions to companies in the world’s largest industries. Explore unique market-leading data today and benefit from access to …
The biggest challenges clinical trials will face in 2025
Jan 16, 2025 · The clinical trial sector reflects on what it believes will be the biggest difficulties of 2025. Image credit: Shutterstock / 3rdtimeluckystudio It has been a turbulent time for the …